BT

Bhupesh Tripathi

Active Director Director DIN 10081646
DIN 10081646 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Bhupesh Tripathi

Data last updated:

Bhupesh Tripathi is a Director at Wellbert Pharmaceuticals (Bombay) Pvt Ltd (since 2023). The company operates in Pharma. Wellbert Pharmaceuticals (Bombay) Pvt Ltd reported revenue of ₹3.81 Cr (FY 2017).

DIN 10081646
Primary Designation Director
Industry Pharma
First Appointment 21 Apr 2023
Oldest Company Age 40 yrs
Largest company Wellbert Pharmaceuticals (Bombay) Pvt Ltd · ₹3.81 Cr (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Apr 20231985₹3.81 Cr (FY 2017)Active

Board colleagues of Bhupesh Tripathi

Directorship timeline

Open interactive timeline →
Wellbert Pharmaceuticals (Bombay) Pvt Ltd
Premium access

Shareholding and investment profile for Bhupesh Tripathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhupesh Tripathi

Bhupesh Tripathi currently holds 1 directorship: Wellbert Pharmaceuticals (Bombay) Pvt Ltd (Director, since 21 Apr 2023, revenue ₹3.81 Cr (FY 2017)).

Bhupesh Tripathi was first appointed on 21 Apr 2023 as Director at Wellbert Pharmaceuticals (Bombay) Pvt Ltd.

The current boards of Bhupesh Tripathi's companies include Mithilesh Mani Tripathi (Wellbert Pharmaceuticals (Bombay) Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available